How to Boost Equity & Inclusion in Cardiovascular & Cancer Trials
Equity in cardiovascular and cancer trials hinges on overcoming patient fears, language barriers, and systemic biases. This analysis details culturally competent engagement and inclusive design strategies aligned with FDA/EMA guidance to foster diverse participation and improve patient outcomes.
Robert Maxwell
Jul 24, 2025
cardiovascular diversity trials
culturally competent research
breast cancer inclusion
anxiety trial access
